How Big Will the SpaceX IPO Be?
Operated up to now as a private business, SpaceX will…
Sell
31
WGS Quote, Financials, Valuation and Earnings
Last price:
$95.13
Seasonality move
:
20.55%
Day range:
$96.50 - $101.50
52-week range:
$55.17 - $170.87
Dividend yield:
0%
P/E ratio:
1,641.96x
P/S ratio:
7.06x
P/B ratio:
9.79x
Volume:
575.1K
Avg. volume:
604.7K
1-year change:
32.28%
Market cap:
$2.9B
Revenue:
$305.5M
EPS (TTM):
$0.06
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
WGS
GeneDx Holdings Corp.
|
$120.4M | $0.12 | 34.88% | -77.01% | $170.00 |
|
DGX
Quest Diagnostics, Inc.
|
$2.8B | $2.36 | 4.11% | 22.45% | $199.31 |
|
GH
Guardant Health, Inc.
|
$271.8M | -$0.47 | 35.29% | -43.18% | $125.24 |
|
ILMN
Illumina, Inc.
|
$1.1B | $1.25 | 2.17% | 37.67% | $135.94 |
|
LH
Labcorp Holdings, Inc.
|
$3.6B | $3.94 | 5.08% | 62.84% | $300.06 |
|
NTRA
Natera, Inc.
|
$603.2M | -$0.53 | 22.18% | -19.94% | $257.20 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
WGS
GeneDx Holdings Corp.
|
$99.01 | $170.00 | $2.9B | 1,641.96x | $0.00 | 0% | 7.06x |
|
DGX
Quest Diagnostics, Inc.
|
$185.00 | $199.31 | $20.6B | 21.71x | $0.80 | 1.73% | 1.93x |
|
GH
Guardant Health, Inc.
|
$114.90 | $125.24 | $14.9B | -- | $0.00 | 0% | 15.80x |
|
ILMN
Illumina, Inc.
|
$141.13 | $135.94 | $21.6B | 31.62x | $0.00 | 0% | 5.19x |
|
LH
Labcorp Holdings, Inc.
|
$270.29 | $300.06 | $22.4B | 26.54x | $0.72 | 1.07% | 1.65x |
|
NTRA
Natera, Inc.
|
$231.10 | $257.20 | $32.2B | -- | $0.00 | 0% | 14.73x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
WGS
GeneDx Holdings Corp.
|
28.13% | 1.929 | 3.68% | 2.47x |
|
DGX
Quest Diagnostics, Inc.
|
46.79% | -0.045 | 30.05% | 0.90x |
|
GH
Guardant Health, Inc.
|
136.47% | 0.817 | 16.98% | 2.94x |
|
ILMN
Illumina, Inc.
|
51.97% | 2.522 | 17.73% | 1.04x |
|
LH
Labcorp Holdings, Inc.
|
42.88% | 0.762 | 27.39% | 1.10x |
|
NTRA
Natera, Inc.
|
13.7% | 1.174 | 0.9% | 3.03x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
WGS
GeneDx Holdings Corp.
|
$79.4M | -$3.1M | 0.56% | 0.82% | -2.68% | $9.6M |
|
DGX
Quest Diagnostics, Inc.
|
$911M | $420M | 7.41% | 14.33% | 14.92% | $419M |
|
GH
Guardant Health, Inc.
|
$171.6M | -$99M | -36.05% | -8518.58% | -37.33% | -$45.8M |
|
ILMN
Illumina, Inc.
|
$732M | $231M | 14.3% | 30.55% | 21.33% | $253M |
|
LH
Labcorp Holdings, Inc.
|
$955.6M | $403.2M | 5.61% | 10.25% | 11.32% | $280.5M |
|
NTRA
Natera, Inc.
|
$384.4M | -$97.6M | -21.88% | -26.6% | -16.48% | $24.5M |
GeneDx Holdings Corp. vs. Competitors
-
Which has Higher Returns WGS or DGX?
Quest Diagnostics, Inc. has a net margin of -6.54% compared to GeneDx Holdings Corp.'s net margin of 9.13%. GeneDx Holdings Corp.'s return on equity of 0.82% beat Quest Diagnostics, Inc.'s return on equity of 14.33%.
Company Gross Margin Earnings Per Share Invested Capital WGSGeneDx Holdings Corp.68.04% -$0.27 $406.6M DGXQuest Diagnostics, Inc.32.35% $2.15 $13.8B -
What do Analysts Say About WGS or DGX?
GeneDx Holdings Corp. has a consensus price target of $170.00, signalling upside risk potential of 71.7%. On the other hand Quest Diagnostics, Inc. has an analysts' consensus of $199.31 which suggests that it could grow by 7.74%. Given that GeneDx Holdings Corp. has higher upside potential than Quest Diagnostics, Inc., analysts believe GeneDx Holdings Corp. is more attractive than Quest Diagnostics, Inc..
Company Buy Ratings Hold Ratings Sell Ratings WGSGeneDx Holdings Corp.7 1 0 DGXQuest Diagnostics, Inc.7 8 0 -
Is WGS or DGX More Risky?
GeneDx Holdings Corp. has a beta of 2.078, which suggesting that the stock is 107.756% more volatile than S&P 500. In comparison Quest Diagnostics, Inc. has a beta of 0.662, suggesting its less volatile than the S&P 500 by 33.785%.
-
Which is a Better Dividend Stock WGS or DGX?
GeneDx Holdings Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Quest Diagnostics, Inc. offers a yield of 1.73% to investors and pays a quarterly dividend of $0.80 per share. GeneDx Holdings Corp. pays -- of its earnings as a dividend. Quest Diagnostics, Inc. pays out 39.15% of its earnings as a dividend. Quest Diagnostics, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios WGS or DGX?
GeneDx Holdings Corp. quarterly revenues are $116.7M, which are smaller than Quest Diagnostics, Inc. quarterly revenues of $2.8B. GeneDx Holdings Corp.'s net income of -$7.6M is lower than Quest Diagnostics, Inc.'s net income of $257M. Notably, GeneDx Holdings Corp.'s price-to-earnings ratio is 1,641.96x while Quest Diagnostics, Inc.'s PE ratio is 21.71x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GeneDx Holdings Corp. is 7.06x versus 1.93x for Quest Diagnostics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income WGSGeneDx Holdings Corp.7.06x 1,641.96x $116.7M -$7.6M DGXQuest Diagnostics, Inc.1.93x 21.71x $2.8B $257M
-
Which has Higher Returns WGS or GH?
Guardant Health, Inc. has a net margin of -6.54% compared to GeneDx Holdings Corp.'s net margin of -34.97%. GeneDx Holdings Corp.'s return on equity of 0.82% beat Guardant Health, Inc.'s return on equity of -8518.58%.
Company Gross Margin Earnings Per Share Invested Capital WGSGeneDx Holdings Corp.68.04% -$0.27 $406.6M GHGuardant Health, Inc.64.71% -$0.74 $971.9M -
What do Analysts Say About WGS or GH?
GeneDx Holdings Corp. has a consensus price target of $170.00, signalling upside risk potential of 71.7%. On the other hand Guardant Health, Inc. has an analysts' consensus of $125.24 which suggests that it could grow by 9%. Given that GeneDx Holdings Corp. has higher upside potential than Guardant Health, Inc., analysts believe GeneDx Holdings Corp. is more attractive than Guardant Health, Inc..
Company Buy Ratings Hold Ratings Sell Ratings WGSGeneDx Holdings Corp.7 1 0 GHGuardant Health, Inc.16 1 1 -
Is WGS or GH More Risky?
GeneDx Holdings Corp. has a beta of 2.078, which suggesting that the stock is 107.756% more volatile than S&P 500. In comparison Guardant Health, Inc. has a beta of 1.631, suggesting its more volatile than the S&P 500 by 63.129%.
-
Which is a Better Dividend Stock WGS or GH?
GeneDx Holdings Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Guardant Health, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. GeneDx Holdings Corp. pays -- of its earnings as a dividend. Guardant Health, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios WGS or GH?
GeneDx Holdings Corp. quarterly revenues are $116.7M, which are smaller than Guardant Health, Inc. quarterly revenues of $265.2M. GeneDx Holdings Corp.'s net income of -$7.6M is higher than Guardant Health, Inc.'s net income of -$92.7M. Notably, GeneDx Holdings Corp.'s price-to-earnings ratio is 1,641.96x while Guardant Health, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GeneDx Holdings Corp. is 7.06x versus 15.80x for Guardant Health, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income WGSGeneDx Holdings Corp.7.06x 1,641.96x $116.7M -$7.6M GHGuardant Health, Inc.15.80x -- $265.2M -$92.7M
-
Which has Higher Returns WGS or ILMN?
Illumina, Inc. has a net margin of -6.54% compared to GeneDx Holdings Corp.'s net margin of 13.85%. GeneDx Holdings Corp.'s return on equity of 0.82% beat Illumina, Inc.'s return on equity of 30.55%.
Company Gross Margin Earnings Per Share Invested Capital WGSGeneDx Holdings Corp.68.04% -$0.27 $406.6M ILMNIllumina, Inc.67.59% $0.97 $5B -
What do Analysts Say About WGS or ILMN?
GeneDx Holdings Corp. has a consensus price target of $170.00, signalling upside risk potential of 71.7%. On the other hand Illumina, Inc. has an analysts' consensus of $135.94 which suggests that it could fall by -3.68%. Given that GeneDx Holdings Corp. has higher upside potential than Illumina, Inc., analysts believe GeneDx Holdings Corp. is more attractive than Illumina, Inc..
Company Buy Ratings Hold Ratings Sell Ratings WGSGeneDx Holdings Corp.7 1 0 ILMNIllumina, Inc.7 8 1 -
Is WGS or ILMN More Risky?
GeneDx Holdings Corp. has a beta of 2.078, which suggesting that the stock is 107.756% more volatile than S&P 500. In comparison Illumina, Inc. has a beta of 1.450, suggesting its more volatile than the S&P 500 by 44.964%.
-
Which is a Better Dividend Stock WGS or ILMN?
GeneDx Holdings Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Illumina, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. GeneDx Holdings Corp. pays -- of its earnings as a dividend. Illumina, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios WGS or ILMN?
GeneDx Holdings Corp. quarterly revenues are $116.7M, which are smaller than Illumina, Inc. quarterly revenues of $1.1B. GeneDx Holdings Corp.'s net income of -$7.6M is lower than Illumina, Inc.'s net income of $150M. Notably, GeneDx Holdings Corp.'s price-to-earnings ratio is 1,641.96x while Illumina, Inc.'s PE ratio is 31.62x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GeneDx Holdings Corp. is 7.06x versus 5.19x for Illumina, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income WGSGeneDx Holdings Corp.7.06x 1,641.96x $116.7M -$7.6M ILMNIllumina, Inc.5.19x 31.62x $1.1B $150M
-
Which has Higher Returns WGS or LH?
Labcorp Holdings, Inc. has a net margin of -6.54% compared to GeneDx Holdings Corp.'s net margin of 7.34%. GeneDx Holdings Corp.'s return on equity of 0.82% beat Labcorp Holdings, Inc.'s return on equity of 10.25%.
Company Gross Margin Earnings Per Share Invested Capital WGSGeneDx Holdings Corp.68.04% -$0.27 $406.6M LHLabcorp Holdings, Inc.26.82% $3.12 $15.2B -
What do Analysts Say About WGS or LH?
GeneDx Holdings Corp. has a consensus price target of $170.00, signalling upside risk potential of 71.7%. On the other hand Labcorp Holdings, Inc. has an analysts' consensus of $300.06 which suggests that it could grow by 11.01%. Given that GeneDx Holdings Corp. has higher upside potential than Labcorp Holdings, Inc., analysts believe GeneDx Holdings Corp. is more attractive than Labcorp Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings WGSGeneDx Holdings Corp.7 1 0 LHLabcorp Holdings, Inc.12 5 0 -
Is WGS or LH More Risky?
GeneDx Holdings Corp. has a beta of 2.078, which suggesting that the stock is 107.756% more volatile than S&P 500. In comparison Labcorp Holdings, Inc. has a beta of 1.029, suggesting its more volatile than the S&P 500 by 2.876%.
-
Which is a Better Dividend Stock WGS or LH?
GeneDx Holdings Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Labcorp Holdings, Inc. offers a yield of 1.07% to investors and pays a quarterly dividend of $0.72 per share. GeneDx Holdings Corp. pays -- of its earnings as a dividend. Labcorp Holdings, Inc. pays out 32.58% of its earnings as a dividend. Labcorp Holdings, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios WGS or LH?
GeneDx Holdings Corp. quarterly revenues are $116.7M, which are smaller than Labcorp Holdings, Inc. quarterly revenues of $3.6B. GeneDx Holdings Corp.'s net income of -$7.6M is lower than Labcorp Holdings, Inc.'s net income of $261.5M. Notably, GeneDx Holdings Corp.'s price-to-earnings ratio is 1,641.96x while Labcorp Holdings, Inc.'s PE ratio is 26.54x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GeneDx Holdings Corp. is 7.06x versus 1.65x for Labcorp Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income WGSGeneDx Holdings Corp.7.06x 1,641.96x $116.7M -$7.6M LHLabcorp Holdings, Inc.1.65x 26.54x $3.6B $261.5M
-
Which has Higher Returns WGS or NTRA?
Natera, Inc. has a net margin of -6.54% compared to GeneDx Holdings Corp.'s net margin of -14.78%. GeneDx Holdings Corp.'s return on equity of 0.82% beat Natera, Inc.'s return on equity of -26.6%.
Company Gross Margin Earnings Per Share Invested Capital WGSGeneDx Holdings Corp.68.04% -$0.27 $406.6M NTRANatera, Inc.64.91% -$0.64 $1.5B -
What do Analysts Say About WGS or NTRA?
GeneDx Holdings Corp. has a consensus price target of $170.00, signalling upside risk potential of 71.7%. On the other hand Natera, Inc. has an analysts' consensus of $257.20 which suggests that it could grow by 11.29%. Given that GeneDx Holdings Corp. has higher upside potential than Natera, Inc., analysts believe GeneDx Holdings Corp. is more attractive than Natera, Inc..
Company Buy Ratings Hold Ratings Sell Ratings WGSGeneDx Holdings Corp.7 1 0 NTRANatera, Inc.13 2 0 -
Is WGS or NTRA More Risky?
GeneDx Holdings Corp. has a beta of 2.078, which suggesting that the stock is 107.756% more volatile than S&P 500. In comparison Natera, Inc. has a beta of 1.636, suggesting its more volatile than the S&P 500 by 63.611%.
-
Which is a Better Dividend Stock WGS or NTRA?
GeneDx Holdings Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Natera, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. GeneDx Holdings Corp. pays -- of its earnings as a dividend. Natera, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios WGS or NTRA?
GeneDx Holdings Corp. quarterly revenues are $116.7M, which are smaller than Natera, Inc. quarterly revenues of $592.2M. GeneDx Holdings Corp.'s net income of -$7.6M is higher than Natera, Inc.'s net income of -$87.5M. Notably, GeneDx Holdings Corp.'s price-to-earnings ratio is 1,641.96x while Natera, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GeneDx Holdings Corp. is 7.06x versus 14.73x for Natera, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income WGSGeneDx Holdings Corp.7.06x 1,641.96x $116.7M -$7.6M NTRANatera, Inc.14.73x -- $592.2M -$87.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will ISRG Stock Be in 5 Years?
Intuitive Surgical (NASDAQ:ISRG) is the innovative medical tech business behind…
Is Kratos Stock a Good Investment?
UAV and hypersonic system defense contractor Kratos (NASDAQ:KTOS) has swung…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
65
Is GOOG Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 43x
Buy
51
Is GOOGL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 43x
Alerts
Sell
49
HYMC alert for Feb 3
Hycroft Mining Holding Corp. [HYMC] is up 19.68% over the past day.
Buy
67
FBRX alert for Feb 3
Forte Biosciences, Inc. [FBRX] is down 0.2% over the past day.
Buy
72
BNR alert for Feb 3
Burning Rock Biotech Ltd. [BNR] is down 15.43% over the past day.
